VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 740 filers reported holding VANECK VECTORS ETF TR in Q1 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $208,092 | -14.7% | 6,433 | +1.3% | 0.15% | -5.6% |
Q1 2022 | $244,000 | +20.2% | 6,353 | 0.0% | 0.16% | +22.0% |
Q4 2021 | $203,000 | +8.6% | 6,353 | +0.0% | 0.13% | +12.8% |
Q3 2021 | $187,000 | -65.2% | 6,352 | -59.9% | 0.12% | -63.8% |
Q2 2021 | $537,000 | +18.5% | 15,822 | +13.3% | 0.32% | +8.0% |
Q1 2021 | $453,000 | +117.8% | 13,960 | +141.2% | 0.30% | +99.3% |
Q4 2020 | $208,000 | -8.0% | 5,787 | +9.1% | 0.15% | -17.6% |
Q3 2020 | $226,000 | -13.7% | 5,304 | -14.3% | 0.18% | -11.2% |
Q2 2020 | $262,000 | +48.0% | 6,187 | -19.8% | 0.20% | +17.1% |
Q1 2020 | $177,000 | -46.4% | 7,719 | -31.4% | 0.18% | -34.7% |
Q4 2019 | $330,000 | +19.6% | 11,256 | +9.0% | 0.27% | -9.5% |
Q3 2019 | $276,000 | – | 10,323 | – | 0.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |